Optimizing Betalactam Clinical Response by Using a Continuous Infusion: A Comprehensive Review.

Sylvain DiamantisCatherine ChakvetadzeAstrid de PontfarcyMatta Matta

Published in: Antibiotics (Basel, Switzerland) (2023)

Clinical data appear to confirm those of PK/PD to use a continuous infusion in severely ill patients or those infected by an organism with an elevated MIC, as it is associated with higher survival rates. In other cases, it may allow for a decrease in antibiotic daily dosage, thereby contributing to a decrease in overall costs.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
low dose
chronic kidney disease
prognostic factors
peritoneal dialysis
electronic health record
machine learning